Michael Hallek
University of Cologne(DE)Düsseldorf University Hospital(DE)Integrated Oncology (United States)(US)National Center for Tumor Diseases(DE)Max Planck Institute for the Study of Societies(DE)Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases(DE)Centrum für Integrierte Onkologie(DE)University Hospital Cologne(DE)Heinrich Heine University Düsseldorf(DE)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines(2008)3,177 cited
- → Comprehensive genomic profiles of small cell lung cancer(2015)2,338 cited
- → Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial(2010)1,860 cited
- → Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia(2014)1,675 cited
- → iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL(2018)1,646 cited
- → Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions(2014)1,490 cited